Sihuan Pharmaceutical Group Ltd. (SHPHF)
Sihuan Pharmaceutical Statistics
Share Statistics
Sihuan Pharmaceutical has 9.24B shares outstanding. The number of shares has increased by -0.4% in one year.
| Shares Outstanding | 9.24B |
| Shares Change (YoY) | -0.4% |
| Shares Change (QoQ) | -0.11% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 4.15B |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -97.73 and the forward PE ratio is null. Sihuan Pharmaceutical's PEG ratio is 1.01.
| PE Ratio | -97.73 |
| Forward PE | n/a |
| PS Ratio | 2.84 |
| Forward PS | n/a |
| PB Ratio | 1.19 |
| P/FCF Ratio | -55.03 |
| PEG Ratio | 1.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Sihuan Pharmaceutical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.51, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.51 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 3.76 |
| Debt / FCF | -13.1 |
| Interest Coverage | 0.6 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $697.61K |
| Profits Per Employee | $-20.25K |
| Employee Count | 2,667 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 1.01 |
Taxes
| Income Tax | 96.43M |
| Effective Tax Rate | -59.8% |
Stock Price Statistics
The stock price has increased by 108.7% in the last 52 weeks. The beta is 0.5, so Sihuan Pharmaceutical's price volatility has been higher than the market average.
| Beta | 0.5 |
| 52-Week Price Change | 108.7% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.07 |
| Relative Strength Index (RSI) | 99.89 |
| Average Volume (20 Days) | 6 |
Income Statement
In the last 12 months, Sihuan Pharmaceutical had revenue of 1.86B and earned -54.02M in profits. Earnings per share was -0.01.
| Revenue | 1.86B |
| Gross Profit | 1.3B |
| Operating Income | 161.7M |
| Net Income | -54.02M |
| EBITDA | 334.31M |
| EBIT | 108.08M |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 3.89B in cash and 1.26B in debt, giving a net cash position of 2.63B.
| Cash & Cash Equivalents | 3.89B |
| Total Debt | 1.26B |
| Net Cash | 2.63B |
| Retained Earnings | 1.34B |
| Total Assets | 11.53B |
| Working Capital | 2.62B |
Cash Flow
In the last 12 months, operating cash flow was 199.49M and capital expenditures -295.42M, giving a free cash flow of -95.93M.
| Operating Cash Flow | 199.49M |
| Capital Expenditures | -295.42M |
| Free Cash Flow | -95.93M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 69.64%, with operating and profit margins of 8.69% and -2.9%.
| Gross Margin | 69.64% |
| Operating Margin | 8.69% |
| Pretax Margin | -8.67% |
| Profit Margin | -2.9% |
| EBITDA Margin | 17.97% |
| EBIT Margin | 8.69% |
| FCF Margin | -5.16% |
Dividends & Yields
SHPHF pays an annual dividend of $0, which amounts to a dividend yield of 4.16%.
| Dividend Per Share | $0.00 |
| Dividend Yield | 4.16% |
| Dividend Growth (YoY) | -42.73% |
| Payout Ratio | -9% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for SHPHF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jun 5, 2014. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 5, 2014 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 0.84 |
| Piotroski F-Score | 3 |